The role of secondary cytoreductive surgery for recurrent ovarian cancer

Gungor M., Ortac F., Arvas M., Kosebay D., Sonmezer M., Kose K.

GYNECOLOGIC ONCOLOGY, vol.97, no.1, pp.74-79, 2005 (SCI-Expanded, Scopus) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 97 Issue: 1
  • Publication Date: 2005
  • Doi Number: 10.1016/j.ygyno.2004.11.057
  • Journal Name: GYNECOLOGIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.74-79
  • Keywords: recurrent ovarian cancer, secondary cytoreduction, chemotherapy, prognosis, DEBULKING SURGERY, CARCINOMA, CISPLATIN, SURVIVAL, THERAPY
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Objective. The aim of this study was to assess the survival benefit of salvage surgical cytoreduction in patients with recurrent ovarian cancer and compare the surgical outcorne with salvage chemotherapy alone.